comparemela.com
Home
Live Updates
Fruquintinib Approval - Breaking News
Pages:
Latest Breaking News On - Fruquintinib approval - Page 7 : comparemela.com
HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global
Recruitment of 687 patients globally completed in fifteen months, ahead of schedule FRESCO-2 primary objective is to confirm overall.
United states
Marek kania
Eli lilly
Fruquintinib development beyond
International corporation
Drug administration
Journal of the american medical association
China limited
China national medical products administration
Japanese pharmaceuticals
European medicines agency
China national reimbursement drug list
Devices agency
Managing director
Chief medical officer
Medical devices agency
Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HUTCHMED Completes Planned Enrollment of FRESCO-2
Investegate announcements from Hutchmed China Ltd, HUTCHMED Completes Planned Enrollment of FRESCO-2
United states
South korea
Hong kong
Mark lee
Zhou yi
Atholl tweedie freddy crossley
Marek kania
Ben atwell alex shaw
Eli lilly
Annie cheng
Fruquintinib development beyond
International corporation
American society of clinical oncology annual meeting
Chinese society of clinical oncology annual meeting
China limited
China national medical products administration
vimarsana © 2020. All Rights Reserved.